200
Participants
Start Date
Not specified
Study Completion Date
November 30, 1997
Stavudine
Zidovudine
Didanosine
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS, Brooklyn
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Children's National Med. Ctr., ACTU, Washington D.C.
Univ. of Florida Jacksonville NICHD CRS, Jacksonville
Univ. of Miami AIDS CRS, Miami
The Ohio State Univ. AIDS CRS, Columbus
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis
Methodist Hosp. of Indiana, Indianapolis
Hennepin County Med. Ctr., Div. of Infectious Diseases, Minneapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
Tulane Hemophilia Treatment Ctr., New Orleans
University of Colorado Hospital CRS, Aurora
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
Stanford CRS, Palo Alto
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Weiss Memorial Hosp., Chicago
University of Minnesota, ACTU, Minneapolis
Washington U CRS, St Louis
Univ. of Cincinnati CRS, Cincinnati
Puerto Rico-AIDS CRS, San Juan
Massachusetts General Hospital ACTG CRS, Boston
Bmc Actg Crs, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
San Juan City Hosp. PR NICHD CRS, San Juan
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH